CellaVision Financials
| CEVI Stock | SEK 214.50 3.00 1.42% |
CellaVision |
Understanding current and past CellaVision Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CellaVision's financial statements are interrelated, with each one affecting the others. For example, an increase in CellaVision's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in CellaVision's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CellaVision AB. Check CellaVision's Beneish M Score to see the likelihood of CellaVision's management manipulating its earnings.
CellaVision Stock Summary
CellaVision competes with Vitrolife, Biotage AB, Sectra AB, BioGaia AB, and Mycronic Publ. CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0000683484 |
| Business Address | Mobilvgen 12, Lund, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.cellavision.com |
| Phone | 46 4 64 60 16 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in CellaVision without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CellaVision Stock, because this is throwing your money away. Analyzing the key information contained in CellaVision's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CellaVision Key Financial Ratios
CellaVision's financial ratios allow both analysts and investors to convert raw data from CellaVision's financial statements into concise, actionable information that can be used to evaluate the performance of CellaVision over time and compare it to other companies across industries.CellaVision Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CellaVision's current stock value. Our valuation model uses many indicators to compare CellaVision value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CellaVision competition to find correlations between indicators driving CellaVision's intrinsic value. More Info.CellaVision AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.58 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CellaVision AB is roughly 1.73 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CellaVision's earnings, one of the primary drivers of an investment's value.CellaVision AB Systematic Risk
CellaVision's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CellaVision volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on CellaVision AB correlated with the market. If Beta is less than 0 CellaVision generally moves in the opposite direction as compared to the market. If CellaVision Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CellaVision AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CellaVision is generally in the same direction as the market. If Beta > 1 CellaVision moves generally in the same direction as, but more than the movement of the benchmark.
CellaVision November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CellaVision help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CellaVision AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of CellaVision AB based on widely used predictive technical indicators. In general, we focus on analyzing CellaVision Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CellaVision's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 13.59 | |||
| Value At Risk | (3.95) | |||
| Potential Upside | 3.46 |
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.